NIH Requests for Applications

  • Limited Competition: A Data Resource for Analyzing Blood and Marrow Transplants (U24)
    (RFA-CA-17-031)
    National Cancer Institute
    National Heart, Lung, and Blood Institute
    Application Receipt Date(s): October 26, 2017), by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date. No late application will be accepted for this FOA. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
  • Chronic Kidney Disease in Children Central Biochemistry Laboratory (U24)
    (RFA-DK-17-034)
    National Institute of Diabetes and Digestive and Kidney Diseases
    Application Receipt Date(s): November 3, 2017,, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
  • Limited Competition for Continuation of the Prospective Study of Chronic Kidney Disease in Children Clinical Coordinating Centers (U01)
    (RFA-DK-17-502)
    National Institute of Diabetes and Digestive and Kidney Diseases
    National Heart, Lung, and Blood Institute
    Eunice Kennedy Shriver National Institute of Child Health and Human Development
    Application Receipt Date(s): November 3, 2017,, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
  • Limited Competition for Continuation of the Prospective Study of Chronic Kidney Disease in Children Data Coordinating Center (U24)
    (RFA-DK-17-503)
    National Institute of Diabetes and Digestive and Kidney Diseases
    Eunice Kennedy Shriver National Institute of Child Health and Human Development
    Application Receipt Date(s): November 3, 2017,, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
  • Limited Competition for the Continuation of the Chronic Renal Insufficiency Cohort (CRIC) Clinical Centers (U01)
    (RFA-DK-17-505)
    National Institute of Diabetes and Digestive and Kidney Diseases
    Application Receipt Date(s): October 26, 2017 by 5:00 PM local time of applicant organization), by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date.
  • Limited Competition for the Continuation of the Chronic Renal Insufficiency Cohort Scientific and Data Coordinating Center (U24)
    (RFA-DK-17-506)
    National Institute of Diabetes and Digestive and Kidney Diseases
    Application Receipt Date(s): October 26, 2017, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date.
  • Limited Competition for the Continuation of the Drug Induced Liver Injury Network (DILIN) Clinical Centers (U01)
    (RFA-DK-17-509)
    National Institute of Diabetes and Digestive and Kidney Diseases
    Application Receipt Date(s): December 5, 2017), by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
  • Limited Competition for the Continuation of the Drug Induced Liver Injury Network Data Coordinating Center (U24)
    (RFA-DK-17-510)
    National Institute of Diabetes and Digestive and Kidney Diseases
    Application Receipt Date(s): December 5, 2017), by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
  • Metabolomics Core for the Undiagnosed Diseases Network (UDN) Phase II (U01)
    (RFA-RM-17-015)
    NIH Roadmap Initiatives
    Application Receipt Date(s): November 2, 2017, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date.
  • Sequencing Core(s) for the Undiagnosed Diseases Network (UDN) Phase II (U01)
    (RFA-RM-17-016)
    NIH Roadmap Initiatives
    Application Receipt Date(s): November 2, 2017, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date.
  • Model Organisms Screening Center for the Undiagnosed Diseases Network (UDN) Phase II (U54)
    (RFA-RM-17-017)
    NIH Roadmap Initiatives
    Application Receipt Date(s): November 2, 2017, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
  • Coordinating Center for the Undiagnosed Diseases Network (UDN) Phase II (U01)
    (RFA-RM-17-018)
    NIH Roadmap Initiatives
    Application Receipt Date(s): November 2, 2017, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.

Clinical Sites for the Undiagnosed Diseases Network (UDN) Phase II (U01)
(RFA-RM-17-019)
NIH Roadmap Initiatives
Application Receipt Date(s): November 2, 2017, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates

| Leave a comment

NIH NOtices

  • Request for Information (RFI): Infrastructure for Research in Nonhuman Primates
    (NOT-OD-17-099) Division of Program Coordination, Planning and Strategic Initiatives, Office of Research Infrastructure Programs
  • Notice of Correction to NOT-OD-17-090 “Request for Information (RFI): Inviting Comments on the Environmental Influences on Child Health Outcomes (ECHO)-wide Cohort Data Collection Protocol”
    (NOT-OD-17-103) National Institutes of Health
  • Notice of Clarification to Eligibility Criteria for PAR-16-268 “Limited Competition: Small Grant Program for NIAMS K08 and K23 Recipients (R03)”
    (NOT-AR-17-019)
    National Institute of Arthritis and Musculoskeletal and Skin Diseases
  • Notice to Update Research Objectives and to Announce Continued Funding for PAS-16-033 “Stimulating Hematology Investigation: New Endeavors (SHINE) (R01)”
    (NOT-DK-17-016)
    National Institute of Diabetes and Digestive and Kidney Diseases
    National Heart, Lung, and Blood Institute
    National Institute on Aging
  • Notice of Change in Eligible Individuals for PAR-16-064 “Small Grants for New Investigators to Promote Diversity in Health-Related Research (R21)”
    (NOT-DK-17-017)
    National Institute of Diabetes and Digestive and Kidney Diseases
  • Notice of Intent to Publish a Funding Opportunity Announcement for NEI Audacious Goals Initiative: Translation-Enabling Models to Evaluate Survival and Integration of Regenerated Neurons in the Visual System (U24)
    (NOT-EY-17-009)
    National Eye Institute
  • Food Safety Preventive Controls and Produce Safety Standards: Building Competency in Latin America in Support of the U.S. Food Safety Modernization Act
    (NOT-FD-17-012)
    Food and Drug Administration
  • Clarification of RFA-HD-18-009 “Global Network for Women’s and Children’s Health Research (UG1)”
    (NOT-HD-17-017)
    Eunice Kennedy Shriver National Institute of Child Health and Human Development
  • Notice of Intent to Publish a Funding Opportunity Announcement for Prevention and Treatment through a Comprehensive Care Continuum for HIV-affected Adolescents in Resource Constrained Settings (PATC3H) (UG3/UH3)
    (NOT-HD-17-021)
    Eunice Kennedy Shriver National Institute of Child Health and Human Development
  • Notice of NICHD’s Participation in PAR-17-314 “Global Brain and Nervous System Disorders Research Across the Lifespan (R01)”
    (NOT-HD-17-022)
    Eunice Kennedy Shriver National Institute of Child Health and Human Development
  • Notice of NICHD’s Participation in PAR-17-313 “Global Brain and Nervous System Disorders Research Across the Lifespan (R21) ”
    (NOT-HD-17-023)
    Eunice Kennedy Shriver National Institute of Child Health and Human Development
  • Notice To Allow Additional Travel Funds for DAP Participants in: Initiative to Maximize Research Education in Genomics: Diversity Action Plan (R25)
    (NOT-HG-17-013)
    National Human Genome Research Institute
  • Notice of Website For Frequently Asked Questions (FAQs) About RFA-HG-17-006 Centers of Excellence in Ethical, Legal and Social Implications (ELSI) Research (CEER) (RM1)
    (NOT-HG-17-015)
    National Human Genome Research Institute
  • Notice of NHLBI Participation in PA-16-043 Revision Applications for Validation of Mobile/Wireless Health Tools for Measurement and Intervention (R01)”
    (NOT-HL-17-534)
    National Heart, Lung, and Blood Institute
  • Notice of NHLBI’s participation on PAR-17-450 “Limited Competition: Lasker Clinical Research Scholars Transition Award (R00)”
    (NOT-HL-17-535)
    National Heart, Lung, and Blood Institute
  • Notice of NIMH’s Interest in Pediatric Pharmacologic Trials in Autism Spectrum Disorders, directed at testing selective GABAergic agents
    (NOT-MH-17-044)
    National Institute of Mental Health
  • Notice to Extend the Expiration Date for PAR-15-195 “NeuroNEXT Infrastructure Resource Access (X01)”
    (NOT-NS-18-003)
    National Institute of Neurological Disorders and Stroke
  • Notice of Clarification of the Device Requirement for RFA-NS-17-005 “BRAIN Initiative: Next-Generation Invasive Devices for Recording and Modulation in the Human Central Nervous System (UG3/UH3)”
    (NOT-NS-18-004)
    National Institute of Neurological Disorders and Stroke
    National Center for Complementary and Integrative Health
    National Eye Institute
    National Institute on Aging
    National Institute on Alcohol Abuse and Alcoholism
    National Institute of Biomedical Imaging and Bioengineering
    Eunice Kennedy Shriver National Institute of Child Health and Human Development
    National Institute on Drug Abuse
    National Institute on Deafness and Other Communication Disorders
    National Institute of Mental Health
  • Notice of Clarification of the Device Requirement for “BRAIN Initiative: Next-Generation Invasive Devices for Recording and Modulation in the Human Central Nervous System (U44)”
    (NOT-NS-18-006)
    National Institute of Neurological Disorders and Stroke
    National Center for Complementary and Integrative Health
    National Eye Institute
    National Institute on Aging
    National Institute on Alcohol Abuse and Alcoholism
    National Institute of Biomedical Imaging and Bioengineering
    Eunice Kennedy Shriver National Institute of Child Health and Human Development
    National Institute on Drug Abuse
    National Institute on Deafness and Other Communication Disorders
    National Institute of Mental Health

Notice of Correction to the Award Budget for the RFA-RM-17-017 “Model Organism Screening Center for the Undiagnosed Diseases Network (UDN) Phase II (U54)”
(NOT-RM-17-037)
NIH Roadmap Initiatives

| Leave a comment

Scientists Develop Tobacco-based Zika Vaccine 

Scientists at Arizona State University (ASU) recently developed a tobacco (plant)-based vaccine that may be safer and less expensive than other Zika vaccine candidates. This vaccine uses a pseudovirus (fake virus) to protect patients. Viruses in the Zika family (flavivirus family) have envelope protein on the outside of the virus. This type of protein was grown first in bacteria and then in tobacco and was ultimately used to create this vaccine. Experiments with mice have shown that the vaccine is 100% effective.

However, this vaccine may offer several advantages over other Zika vaccine candidates. Exposure to one disease (including exposure to some types of vaccine) may cause much more severe sickness if the person later becomes infected with a related disease. This particular vaccine uses only a small part of the envelope, so it does not cause the person’s immune system to react to related viruses like dengue. This means that the vaccine may be safer for someone who may later be infected with dengue.

Further, some vaccines – including one developed for Zika – use viruses deactivated by heat. Unfortunately, the vaccine may accidentally cause infection if a batch of vaccine is incorrectly produced.

Although research like this is promising, there is still currently NO VACCINE or specific treatment for Zika virus.

Learn more general information about how vaccines work HERE

Read an ASU article about the vaccine research HERE

Read the scientific journal article published HERE

| Leave a comment

Epidemiology Program for American Indian/Alaska Native Tribes and Urban Indian Communities – Competing Supplement

The purpose of this cooperative agreement is to strengthen public health capacity and to fund Tribes, Tribal and Urban Indian organizations, and intertribal consortia in identifying relevant health status indicators and priorities using sound epidemiologic principles. Work-plans submitted in response to this announcement must clearly state the grantee’s desired objectives and address at least one of the Recipient Activities under this announcement. Recipient Activities may address one or all of the below two groups of activities: A) NIH, NIMHD Activities A1) Development and implementation of data collection efforts to identify and document health disparities experienced by American Indian / Alaska Native (AI/AN) populations; A2) Compilation of existing data (e.g., healthcare utilization, vital statistics data) to generate health profiles and document health disparities in AI/AN populations; A3) Implementation and evaluation of public health awareness campaigns to increase knowledge and attention to significant high priority health issues in AI/AN communities; and A4) Implementation and evaluation of public health interventions to promote health or address disparities in AI/AN communities. B) CDC, NCEH Activities B1) Establish data sources to pilot-test Tribal data within the Tracking Network, a Web-based system of environmental health data and information; B2) Identify and work with Tribal partners to use environmental health data and data outputs relevant to local decision-making and implementing environmental health interventions; B3) Establish indicators for the priorities identified; B4) Work with CDC to address confidentiality concerns through methods such as temporal aggregation and suppression; B5) Work with CDC to develop content for the AI/AN web pages on the Tracking Network and to establish the data displays for Tribal data, such as maps or charts to visualize Tribal data; B6) Work with CDC and its partners to explore the application of Tribal data to environmental public health; B7) Build environmental epidemiology capacity within the Tribal Epidemiology Centers (TEC); B8) Provide assistance to fellow TECs regarding Tribal issues with addressing environmental health data gaps; and B9) Present results from environmental health data assessment and promote pilot project methodology and outcomes to other TECs
| Leave a comment

Preventing Alcohol-Related Deaths through Social Detoxification

The purpose of this IHS cooperative agreement is to increase access to community-based prevention strategies to provide social detoxification, evaluation, stabilization, fostering patient readiness for and entry into treatment for alcohol use disorders and when appropriate, other substance use disorders. Applicants must have a fully operational and staffed social detoxification program that provides all three critical components of the detoxification process that primarily serves Indians. Indian Health Service (IHS) will use this funding to focus on the provision of services in the Navajo and Great Plains Areas. Congress has highlighted that the community of Gallup, New Mexico, continues to face urgent needs for substance abuse treatment, residential services, and detoxification services to address an ongoing crisis of alcohol-related deaths of Tribal members. Senate Appropriations Committee Report 114-281 expressed the Committee’s expectation that IHS use funds provided in its appropriation to continue its assistance toward addressing this issue in the city of Gallup, New Mexico. Additionally, IHS is aware of the urgent need for alcohol detoxification services in the Great Plains Area after the removal of liquor licenses in White Clay, Nebraska, leading to the potential for increased mortality if services are unavailable for alcohol detoxification and subsequent treatment services

 

| Leave a comment

Preventing Alcohol-Related Deaths

Preventing Alcohol-Related Deaths

The purpose of the IHS Preventing Alcohol-Related Deaths cooperative agreement is to increase access to community-based prevention strategies to provide social detoxification, evaluation, stabilization, fostering patient readiness for and entry into treatment for alcohol use disorders and when appropriate, other substance use disorders. Applicants must have a fully operational and staffed social detoxification program that provides all three critical components of the detoxification process that primarily serves Indians.

 

IHS will use this funding to focus on the provision of services in the Navajo and Great Plains Areas. Congress has highlighted that the community of Gallup, New Mexico, continues to face urgent needs for substance abuse treatment, residential services, and detoxification services to address an ongoing crisis of alcohol-related deaths of Tribal members. Senate Appropriations Committee Report 114-281 expressed the Committee’s expectation that IHS use funds provided in its appropriation to continue its assistance toward addressing this issue in the city of Gallup, New Mexico. Additionally, IHS is aware of the urgent need for alcohol detoxification services in the Great Plains Area. IHS anticipates making two awards: 1 for Navajo and 1 for Great Plains. Applications are due on September 14, 2017. More information for applicants is available at 2017-17102<https://www.federalregister.gov/documents/2017/08/14/2017-17102/preventing-alcohol-related-deaths-pard-through-social-detoxification?utm_campaign=subscription%20mailing%20list&utm_source=federalregister.gov&utm_medium=email

| Leave a comment

Behavioral Health Integration Initiative The purpose of the IHS Behavioral Health Integration Initiative (BH2I)

Behavioral Health Integration Initiative The purpose of the IHS Behavioral Health Integration Initiative (BH2I) grant opportunity is to improve the physical and mental health status of people with behavioral health issues by developing an integrative, coordinated system of care between behavioral health and primary care providers. This effort supports the IHS mission to raise the physical, mental, social and spiritual health of AI/ANs to the highest level. Increasing capacity among IHS, Tribal, and Urban Indian Organization (I/T/U) health facilities to implement an integrative approach in the delivery of behavioral health services, including trauma-informed care, nutrition, exercise, social, spiritual, cultural, and primary care services will improve morbidity and mortality outcomes among the AI/AN population. In addition, this effort will support activities that address improving the quality of life for individuals suffering from mental illness, substance use disorders, and adverse childhood experiences. Other outcomes related to this effort include improved behavioral health services that will increase access to integrated health and social well-being services and the early identification and intervention of mental health, substance use, and serious physical health issues, including chronic disease. Applications for $500,000 are due September 14, 2017. More information for grantees is available at 2017-17103<https://www.federalregister.gov/documents/2017/08/14/2017-17103/division-of-behavioral-health-office-of-clinical-and-preventive-services-behavioral-health?utm_campaign=subscription%20mailing%20list&utm_source=federalregister.gov&utm_medium=email>.

 

IHS Federal facilities: IHS-operated facilities may apply for a BH2I Federal program award. Please visit https://www.ihs.gov/dbh/newsannouncements/fundingannouncement/ for more information.

| Leave a comment